Search clinical trials for: 2019-nCoV Disease

Total 381441 results

Sinovac Life Sciences Co., Ltd.

Recruiting

SA55 Injection Phase II Study in the Treatment of Mild/Moderate COVID-19 Patients

Infection of Upper Respiratory Tract Caused by 2019-nCoV

China
Sinopharm Wuhan Plasma-derived Biotherapies Co....
China National Biotec Group Company Limited; Beijing Tiantan Biological Products...

Not yet recruiting

Human COVID-19 Immunoglobulin (COVID-HIG) Therapy for COVID-19 Patients

COVID-19

United Arab Emirates
Vanderbilt University Medical Center

Recruiting

Post Acute Sequelae of COVID-19 (PASC)

Covid19 | Pulmonary Fibrosis | Sars-CoV-2 Infection | COVID-19 Acute Respiratory Distress Syndrome | Dyspnea Caused by 2019-nCoV

United States
Chelsea and Westminster NHS Foundation Trust

Recruiting

PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs (PHENOTYPE)

COVID-19 | Corona Virus Infection | Coronavirus | 2019 Novel Coronavirus Infection | 2019nCoV

United Kingdom
National Research Centre, Egypt
Egyptian Military Medical Services

Not yet recruiting

Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease (COVID-19_LF)

COVID-19 | Coronavirus Infection | SARS-CoV 2 | Acute Respiratory Distress Syndrome | Corona Virus Infection | Middle East Respiratory Syndrome (MERS)

Egypt
Institut National de la Santé Et de la Recherche...

Recruiting

French COVID Cohort (FrenchCOVID)

Coronavirus Infections

France
The First Affiliated Hospital of Soochow University

Withdrawn

Clinical Study on the Impact of Covid-19 Vaccine on Allogeneic Hematopoietic Stem Cell Transplantation

Hematologic Diseases

China
National Institute of Allergy and Infectious Diseases...
ModernaTX, Inc.

Completed

Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)

COVID-19 | COVID-19 Immunisation

United States
Leidos Life Sciences
United States Department of Defense

Withdrawn

Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection
Leidos Life Sciences
United States Department of Defense

Active, not recruiting

LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection

United States
Jeffrey Bluestone
National Institute of Allergy and Infectious Diseases (NIAID); Immune Tolerance...

Terminated

Tregs for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Associated With COVID-19 (regARDS) (regARDS)

Acute Respiratory Distress Syndrome Due to Disease Caused by 2019-nCoV

United States
R-Pharm
Federal Budget Institution of Science "Central Research Institute of Epidemiology... and other collaborators

Active, not recruiting

Study of Efficacy of Different Treatment Regimens of Olokizumab (RESET)

COVID-19

Russian Federation
R-Pharm

Completed

Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19

COVID-19

Russian Federation
R-Pharm
Data Management 365; Almedis LLC; ScienceFiles LLC

Completed

Study of the Outcomes of Olokizumab Therapy in Hospitalized Patients With SARS-CoV-2 (COVID-19) Infection (ROCOVI)

COVID-19

Russian Federation
R-Pharm
AstraZeneca

Completed

Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)

COVID-19

United Arab Emirates
Leidos Life Sciences
United States Department of Defense

Terminated

Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection

United States
AudibleHealth AI, Inc.
Sunrise Research Institute; Analytical Solutions Group, Inc.; Kelley Medical... and other collaborators

Completed

Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation

Coronavirus Disease 2019 | SARS-CoV-2 Infection | COVID-19 Pandemic | COVID-19 Virus Infection | Coronavirus Disease-19 | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease

United States
R-Pharm
AstraZeneca; Russian Direct Investment Fund; The Gamaleya National Center of...

Completed

Open-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD1222 and rAd26-S for COVID-19 Prevention

COVID-19

Azerbaijan
AudibleHealth AI, Inc.
University of South Florida; Analytical Solutions Group, Inc.; R. P. Chiacchierini... and other collaborators

Completed

Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness

COVID19

United States
Institut National de la Santé Et de la Recherche...

Suspended

Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19. (Cov-CONTACT)

Coronavirus

France, French Guiana
Inova Health Care Services

Completed

Characteristics of COVID-19 Infection Among PREGnant Women (CCOVID-PREG)

Pregnancy Related | Corona Virus Infection

United States
First Affiliated Hospital of Zhejiang University
Ascletis Pharmaceuticals Co., Ltd.

Terminated

Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection

2019-nCoV

China
University of Pecs

Terminated

Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary (PROACTIVE-19)

COVID-19 | SARS-CoV-2 | Coronavirus | 2019-nCoV | 2019nCoV

Hungary
Universidad Católica de Honduras
Pontificia Universidad Catolica de Chile

Completed

Safety and Efficacy of Thymic Peptides in the Treatment of Hospitalized COVID-19 Patients in Honduras

COVID-19

Honduras
R-Pharm International, LLC
Data Management 365; K-Research, LLC

Completed

Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)

COVID-19

Russian Federation
Promomed, LLC
Solyur Pharmaceuticals Group

Completed

Randomized Multicenter Study on the Efficacy and Safety of Favipiravir for Parenteral Administration Compared to Standard of Care in Hospitalized Patients With COVID-19

COVID-19

Russian Federation
Viriom

Completed

An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers

Covid19 | HIV-1-infection

Russian Federation
Assistance Publique - Hôpitaux de Paris

Completed

Interest of the Use of Pulmonary Ultrasound in the Referral of Patients With or Suspected COVID-19 + (eChoVid)

Interstitial Pneumonia | 2019-nCoV (COVID-19)

France
R-Pharm
Covance; Cromos Pharma LLC

Withdrawn

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

COVID-19
Jieming QU

Completed

Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus

2019-nCoV

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Unknown

Evaluation of Clinical Equivalence Between Two Linaclotide Products in the Treatment of Chronic Idiopathic Constipation

Chronic Idiopathic Constipation

China
Assistance Publique - Hôpitaux de Paris

Unknown

Educational Interventions for Surgeons During COVID-19 Pandemic: Cross-sectional, E-survey (EDUCOVID)

COVID-19

France
Hospital Israelita Albert Einstein
Hospital do Coracao; Hospital Sirio-Libanes; Brazilian Research In Intensive... and other collaborators

Completed

Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)

Coronavirus Infections | Pneumonia, Viral

Brazil
Promomed, LLC

Completed

Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19

COVID-19

Russian Federation
Università degli Studi dell'Insubria

Completed

Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19)

COVID-19 | SARS-CoV 2 | Corona Virus Infection

Italy
Providence Health & Services
Providence Cancer Center, Earle A. Chiles Research Institute; Center for Outcomes...

Suspended

Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care

COVID-19 | Corona Virus Infection | SARS-CoV-2 | 2019-nCoV | 2019 Novel Coronavirus

United States
Hospital Sirio-Libanes
Hospital Israelita Albert Einstein; Ache Laboratorios Farmaceuticos S.A.; Hospital... and other collaborators

Terminated

COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III (CoDEX)

Coronavirus Infection | Pneumonia, Viral | Acute Respiratory Distress Syndrome

Brazil
Chromis LLC
Chemical Diversity Research Institute

Unknown

An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19

COVID-19

Russian Federation
CCTU- Cancer Theme

Unknown

Evaluation of Novel Diagnostic Tests for COVID-19 (COVIDx)

Acute Disease | Coronavirus | Respiratory Viral Infection

United Kingdom
Second Affiliated Hospital of Wenzhou Medical University
Wanbangde Pharmaceutical Group Co., LTD

Unknown

Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)

Novel Coronavirus Pneumonia | 2019-nCoV

China
Dr Gerry Gin Wai Kwok
The University of Hong Kong

Unknown

COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1

COVID-19 | Pneumonia, Viral | SARS-CoV-2 | 2019-nCoV
Shahid Beheshti University of Medical Sciences

Unknown

Interferon Beta 1a in Hospitalized COVID-19 Patients (IB1aIC)

COVID-19

Iran, Islamic Republic of
The University of Hong Kong
Hospital Authority, Hong Kong

Completed

Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment

Novel Coronavirus Infection

Hong Kong
Beijing Ditan Hospital

Unknown

Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV

New Coronavirus

China
Shanghai Jiao Tong University School of Medicine

Unknown

Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff

2019 Novel Coronavirus Infection

China
Tongji Hospital

Unknown

A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia

2019-nCoV

China
Chongqing Medical University

Withdrawn

Prognositc Factors in COVID-19 Patients Complicated With Hypertension

2019-nCoV

China
Tongji Hospital

Unknown

The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia

2019-nCoV Severe Pneumonia

China
The Second Hospital of Nanjing Medical University

Withdrawn

Washed Microbiota Transplantation for Patients With 2019-nCoV Infection

COVID-19 Complicated With Refractory Intestinal Infections

China
Tongji Hospital

Unknown

A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia

2019-nCoV Pneumonia

China

Search clinical trials for: 2019-nCoV Disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations